Commit To Buy Forest Laboratories At $87.50, Earn 8.3% Annualized Using Options

Investors eyeing a purchase of Forest Laboratories, Inc. ( FRX) stock, but tentative about paying the going market price of $92.24/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $87.50 strike, which has a bid at the time of this writing of $4.00. Collecting that bid as the premium represents a 4.6% return against the $87.50 commitment, or a 8.3% annualized rate of return (at Stock Options Channel we call this the YieldBoost).

START SLIDESHOW:
Top YieldBoost Puts of the S&P 500 »

Selling a put does not give an investor access to FRX's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $87.50 strike if doing so produced a better outcome than selling at the going market price. ( Do options carry counterparty risk? This and six other common options myths debunked). So unless Forest Laboratories, Inc. sees its shares fall 5% and the contract is exercised (resulting in a cost basis of $83.50 per share before broker commissions, subtracting the $4.00 from $87.50), the only upside to the put seller is from collecting that premium for the 8.3% annualized rate of return.

Below is a chart showing the trailing twelve month trading history for Forest Laboratories, Inc., and highlighting in green where the $87.50 strike is located relative to that history:

Loading+chart++2014+TickerTech.com

The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the November put at the $87.50 strike for the 8.3% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Forest Laboratories, Inc. (considering the last 251 trading day closing values as well as today's price of $92.24) to be 38%. For other put options contract ideas at the various different available expirations, visit the FRX Stock Options page of StockOptionsChannel.com.

If you liked this article you might like

Cramer: There Are Some Bargains Out There

Cramer: There Are Some Bargains Out There

Teva, Actavis, Other Generic Drugmakers May Be on Acquisition Trail

Teva, Actavis, Other Generic Drugmakers May Be on Acquisition Trail

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Why Endo International Can Deliver Solid Rewards With Minimal Risk

Why Endo International Can Deliver Solid Rewards With Minimal Risk

3 Stocks Driving The Health Care Sector Higher

3 Stocks Driving The Health Care Sector Higher